CAXG up 140% on SFDA approval
"This looks like a runner"
China Aoxing Pharmaceutical Company Announces Product Launch of Naloxone Hydrochloride
NEW YORK, Feb. 21 /PRNewswire-FirstCall/ -- China Aoxing Pharmaceutical Company, Inc. (OTC Bulletin Board: CAXG), a pharmaceutical company based in China that has developed a patented manufacturing process for a variety of generic analgesic drugs, including Oxycodone, Pholcodine, Naloxone, and Tilidine, today announced the product launch of Naloxone Hydrochloride ("Naloxone") in China. The Company is authorized by the China State Food and Drug Administration ("SFDA") to manufacture injectable Naloxone
My observations are forecasts, not predictions. Your weather may vary.
